24 May 2013
Keywords: fda, panel, backs, merck, chickenpox, vaccine, co
Article | 07 February 1994
Merck & Co's Varivax chickenpox vaccine is safe and effective for the
short-term protection of children, but the long-term efficacy of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 February 1994
23 May 2013
© 2013 thepharmaletter.com